title: Generation and characterization of a stable soluble guanylate cyclase-overexpressing CHO cell line.
abstract: A stably transfected soluble guanylate cyclase (sGC, alpha1 and beta1 subunits of the rat lung enzyme)-overexpressing CHO cell line was generated for the characterization of different types of activators of the soluble guanylate cyclase. Polyclonal antibodies directed against both subunits of the rat enzyme were used to detect both subunits in the cytosol of the transfected CHO cells. We studied the effects of different nitric oxide (NO) donors like SNP and DEA/NO and, in particular, the direct, NO-independent stimulator of the soluble guanylate cyclase 3-(5'-hydroxymethyl-2'furyl)-1-benzyl indazole (YC-1), on intracellular guanosine 3',5'-cyclic monophosphate (cGMP) production. DEA/NO (0.01-3 microM), SNP (1-10 microM), and YC-1 (1-10 microM) induced a concentration-dependent intracellular cGMP increase with maximal effects of 16-fold (3 microM DEA/NO), 8-fold (10 microM SNP), and 6-fold (10 microM YC-1) stimulation compared to controls, respectively. In addition, a synergistic effect of the combination of the NO donor and YC-1 could be observed with a maximal stimulation of 64-fold by SNP (10 microM) and YC-1 (10 microM). 1H-(1,2,4)-Oxadiazolo-(4,3-a)-6-bromo-quinoxazin-1-one (ODQ, 10 microM), a potent and selective inhibitor of sGC, inhibited both the single effects of NO donors [DEA/NO (3 microM), 77%; SNP (3 microM), 83%] and YC-1 [YC-1 (3 microM), 82%], but moreover the synergistic effects between NO donors and YC-1 [DEA/NO (3 microM) + YC-1 (3 microM), 81%; SNP (3 microM) + YC-1 (3 microM),89%] on intracellular cGMP production. In summary,we have generated a simple, sensitive, and useful bioassay method to characterize all types of sGC activators on the cellular level without the need of primary cell culture, several transfections, or purifying enzyme from biological materials.
authors.affiliation: Institute of Cardiovascular and Arteriosclerosis Research, Bayer AG, Wuppertal, Germany.
authors.forename: E M
authors.initials: EM
authors.lastname: Becker
authors.forename: F
authors.initials: F
authors.lastname: Wunder
authors.forename: R
authors.initials: R
authors.lastname: Kast
authors.forename: C
authors.initials: C
authors.lastname: Robyr
authors.forename: M
authors.initials: M
authors.lastname: Hoenicka
authors.forename: R
authors.initials: R
authors.lastname: Gerzer
authors.forename: H
authors.initials: H
authors.lastname: Schröder
authors.forename: J P
authors.initials: JP
authors.lastname: Stasch
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D016466:CHO Cells; D006224:Cricetinae; D006152:Cyclic GMP / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006162:Guanylate Cyclase / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000235:genetics*; D008969:Molecular Sequence Data; D020030:Nitric Oxide Donors / Q000494:pharmacology; D010446:Peptide Fragments / Q000737:chemistry; D051381:Rats; D014162:Transfection
chemical_list: D004791:Enzyme Inhibitors; D020030:Nitric Oxide Donors; D010446:Peptide Fragments; D006162:Guanylate Cyclase; D006152:Cyclic GMP